During the past decade, Houston Neurocare conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Houston Neurocare" are "Acute Treatment of Migraine" (1 trials), "Diabetic Peripheral Neuropathy" (1 trials), "Painful Diabetic Neuropathies" (1 trials), "Painful Diabetic Peripheral Neuropathy" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "Houston Neurocare" in a lesser frequency.

Most popular intervention types in "Houston Neurocare" are "Drug" (4 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "Control- Placebo (normal saline)" (1 trials), "High Dose: 32 mg VM202" (1 trials), "Low Dose: 16 mg VM202" (1 trials) and "Matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Houston Neurocare" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Houston Neurocare". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Houston Neurocare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Houston Neurocare, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".